Top list · Worldwide
24 CRISPR startups worldwide have raised money in rounds we track. These are the 24 that have raised the most, $1.6B between them, with the United States the most common home.
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Founded 2014United States$550Mlast round Mar 2026Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Founded 2012Menlo Park, United States$319Mlast round Feb 2022KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Founded 2015Lexington, United States$156Mlast round Sept 2018Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Founded 2011Berkeley, United States$139Mlast round Jul 2023Arbor Biotechnologies is a gene editing company based in Cambridge, Massachusetts, dedicated to developing genomic medicines for a variety of genetic diseases.
Founded 2016Cambridge, United States$74Mlast round Mar 2025Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Founded 2015Morrisville, United States$54Mlast round May 2022YolTech Therapeutics is a clinical-stage biotechnology company based in Shanghai, China, founded in 2021.
Founded 2021Shanghai, China$42Mlast round Sept 2025Recombinetics is a biotechnology company based in St.
Founded 2008New Brighton, United States$39Mlast round Aug 2018GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Founded 2016South San Francisco, United States$33Mlast round Jan 2024Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Founded 2017Alameda, United States$33Mlast round Jul 2026Amber Bio is a biotechnology company focused on advancing genetic medicine through innovative RNA-based therapeutic platforms.
Founded 2022Cambridge, United States$26Mlast round Aug 2023VedaBio is a biotechnology company based in San Diego, California, founded in 2021.
Founded 2021San Diego, United States$25Mlast round Sept 2025Pairwise is an agricultural biotechnology company based in Durham, North Carolina, founded in 2017 by Dr.
Founded 2017Durham, United States$25Mlast round Mar 2018Aurora Therapeutics is a biotechnology company based in Cambridge, Massachusetts, specializing in personalized gene editing for rare diseases.
Founded -Cambridge, United States$16Mlast round Jan 2026Biocentis is a biotechnology company based in London and Milan, focused on developing eco-friendly insect control solutions.
Founded 2022Bresso, United Kingdom$13Mlast round Nov 2025CRISPR QC is a biotechnology company based in San Diego, founded in 2021.
Founded 2021San Diego, United States$10Mlast round Jan 2024Editpep is a biotechnology business.
Founded -Berkeley, United States$8.2Mlast round Dec 2024Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Founded 2015Philadelphia, United States$6.8Mlast round Sept 2022Algen Biotechnologies is a precision therapeutics company focused on next-generation drug discovery through CRISPR gene modulation and artificial intelligence.
Founded 2018San Francisco, United States$5.4Mlast round Aug 2021Desktop Genetics is a UK-based bioinformatics and biotechnology company founded in 2012 by three graduates from the University of Cambridge.
Founded 2012Cambridge, United Kingdom$5.1Mlast round Nov 2019Alia Therapeutics is an innovative biotechnology company based in Trento, Italy, founded in October 2018.
Founded 2018Trento, Italy$4.8Mlast round Apr 2023Forge Genetics is a pioneering provider of gene-editing technology.
Founded 2023Nottingham, United Kingdom$3.0Mlast round Oct 2025Synvect is a biotechnology startup based in San Diego, founded in 2022.
Founded 2022San Diego, United States$3.0Mlast round Mar 2025Ivy Natal is a biotechnology company dedicated to enhancing human fertility and animal agriculture through innovative technologies.
Founded 2020San Francisco, United States$1.5Mlast round Jan 2022Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back cRISPR startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B